ID   ALG2_HUMAN              Reviewed;         416 AA.
AC   Q9H553; A2A2Y0; Q8NBX2; Q8NC39;
DT   13-APR-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 1.
DT   12-APR-2017, entry version 144.
DE   RecName: Full=Alpha-1,3/1,6-mannosyltransferase ALG2;
DE            EC=2.4.1.132;
DE            EC=2.4.1.257;
DE   AltName: Full=Asparagine-linked glycosylation protein 2 homolog;
DE   AltName: Full=GDP-Man:Man(1)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase;
DE   AltName: Full=GDP-Man:Man(1)GlcNAc(2)-PP-dolichol mannosyltransferase;
DE   AltName: Full=GDP-Man:Man(2)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase;
GN   Name=ALG2; ORFNames=UNQ666/PRO1298;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Takahashi T., Katoh R., Okutomi S., Suzuki Y., Mori H., Takizawa Y.,
RA   Nishikawa Y.;
RT   "Molecular cloning of the mammalian genes which complement the defect
RT   of the yeast alg2 mutation.";
RL   Submitted (JAN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RX   PubMed=12975309; DOI=10.1101/gr.1293003;
RA   Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J.,
RA   Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P.,
RA   Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S.,
RA   Huang A., Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J.,
RA   Lewis L., Liao D., Mark M.R., Robbie E., Sanchez C., Schoenfeld J.,
RA   Seshagiri S., Simmons L., Singh J., Smith V., Stinson J., Vagts A.,
RA   Vandlen R.L., Watanabe C., Wieand D., Woods K., Xie M.-H.,
RA   Yansura D.G., Yi S., Yu G., Yuan J., Zhang M., Zhang Z., Goddard A.D.,
RA   Wood W.I., Godowski P.J., Gray A.M.;
RT   "The secreted protein discovery initiative (SPDI), a large-scale
RT   effort to identify novel human secreted and transmembrane proteins: a
RT   bioinformatics assessment.";
RL   Genome Res. 13:2265-2270(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Placenta;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E.,
RA   Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S.,
RA   Babbage A.K., Babbage S., Bagguley C.L., Bailey J., Banerjee R.,
RA   Barker D.J., Barlow K.F., Bates K., Beasley H., Beasley O., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burford D., Burrill W.,
RA   Burton J., Carder C., Carter N.P., Chapman J.C., Chen Y., Clarke G.,
RA   Clark S.Y., Clee C.M., Clegg S., Collier R.E., Corby N., Crosier M.,
RA   Cummings A.T., Davies J., Dhami P., Dunn M., Dutta I., Dyer L.W.,
RA   Earthrowl M.E., Faulkner L., Fleming C.J., Frankish A.,
RA   Frankland J.A., French L., Fricker D.G., Garner P., Garnett J.,
RA   Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M.,
RA   Lovell J., Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S.,
RA   McLay K.E., McMurray A., Milne S., Nickerson T., Nisbett J.,
RA   Nordsiek G., Pearce A.V., Peck A.I., Porter K.M., Pandian R.,
RA   Pelan S., Phillimore B., Povey S., Ramsey Y., Rand V., Scharfe M.,
RA   Sehra H.K., Shownkeen R., Sims S.K., Skuce C.D., Smith M.,
RA   Steward C.A., Swarbreck D., Sycamore N., Tester J., Thorpe A.,
RA   Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Williams S.A., Wilming L., Wray P.W.,
RA   Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S.,
RA   Rogers J., Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Embryonic testis carcinoma;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   FUNCTION, AND INVOLVEMENT IN CDG1I.
RX   PubMed=12684507; DOI=10.1074/jbc.M302850200;
RA   Thiel C., Schwarz M., Peng J., Grzmil M., Hasilik M., Braulke T.,
RA   Kohlschuetter A., von Figura K., Lehle L., Koerner C.;
RT   "A new type of congenital disorders of glycosylation (CDG-Ii) provides
RT   new insights into the early steps of dolichol-linked oligosaccharide
RT   biosynthesis.";
RL   J. Biol. Chem. 278:22498-22505(2003).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [8]
RP   INVOLVEMENT IN CMS14, VARIANT CMS14 GLY-68, AND CHARACTERIZATION OF
RP   VARIANT CMS14 GLY-68.
RX   PubMed=23404334; DOI=10.1093/brain/awt010;
RG   WGS500 Consortium;
RA   Cossins J., Belaya K., Hicks D., Salih M.A., Finlayson S., Carboni N.,
RA   Liu W.W., Maxwell S., Zoltowska K., Farsani G.T., Laval S.,
RA   Seidhamed M.Z., Donnelly P., Bentley D., McGowan S.J., Muller J.,
RA   Palace J., Lochmuller H., Beeson D., Donnelly P., Bell J., Bentley D.,
RA   McVean G., Ratcfliffe P., Taylor J., Wilkie A., Donnelly P.,
RA   Broxholme J., Buck D., Cazier J.B., Cornall R., Gregory L., Knight J.,
RA   Lunter G., McVean G., Taylor J., Tomlinson I., Wilkie A., Buck D.,
RA   Allan C., Attar M., Green A., Gregory L., Humphray S., Kingsbury Z.,
RA   Lamble S., Lonie L., Pagnamenta A., Piazza P., Polanco G., Trebes A.,
RA   McVean G., Donnelly P., Cazier J.B., Broxholme J., Copley R.,
RA   Fiddy S., Grocock R., Hatton E., Holmes C., Hughes L., Humburg P.,
RA   Kanapin A., Lise S., Lunter G., Martin H., Murray L., McCarthy D.,
RA   Rimmer A., Sahgal N., Wright B., Yau C.;
RT   "Congenital myasthenic syndromes due to mutations in ALG2 and ALG14.";
RL   Brain 136:944-956(2013).
CC   -!- FUNCTION: Mannosylates Man(2)GlcNAc(2)-dolichol diphosphate and
CC       Man(1)GlcNAc(2)-dolichol diphosphate to form Man(3)GlcNAc(2)-
CC       dolichol diphosphate. {ECO:0000269|PubMed:12684507}.
CC   -!- CATALYTIC ACTIVITY: GDP-D-mannose + D-Man-beta-(1->4)-D-GlcNAc-
CC       beta-(1->4)-D-GlcNAc-diphosphodolichol = GDP + D-Man-alpha-(1->3)-
CC       D-Man-beta-(1->4)-D-GlcNAc-beta-(1->4)-GlcNAc-diphosphodolichol.
CC   -!- CATALYTIC ACTIVITY: GDP-D-mannose + D-Man-alpha-(1->3)-D-Man-beta-
CC       (1->4)-D-GlcNAc-beta-(1->4)-D-GlcNAc-diphosphodolichol = GDP + D-
CC       Man-alpha-(1->3)-(D-Man-alpha-(1->6))-D-Man-beta-(1->4)-D-GlcNAc-
CC       beta-(1->4)-D-GlcNAc-diphosphodolichol.
CC   -!- PATHWAY: Protein modification; protein glycosylation.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Single-pass membrane
CC       protein {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9H553-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9H553-2; Sequence=VSP_013188, VSP_013189;
CC   -!- DISEASE: Congenital disorder of glycosylation 1I (CDG1I)
CC       [MIM:607906]: A form of congenital disorder of glycosylation, a
CC       multisystem disorder caused by a defect in glycoprotein
CC       biosynthesis and characterized by under-glycosylated serum
CC       glycoproteins. Congenital disorders of glycosylation result in a
CC       wide variety of clinical features, such as defects in the nervous
CC       system development, psychomotor retardation, dysmorphic features,
CC       hypotonia, coagulation disorders, and immunodeficiency. The broad
CC       spectrum of features reflects the critical role of N-glycoproteins
CC       during embryonic development, differentiation, and maintenance of
CC       cell functions. {ECO:0000269|PubMed:12684507}. Note=The disease is
CC       caused by mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Myasthenic syndrome, congenital, 14 (CMS14) [MIM:616228]:
CC       A form of congenital myasthenic syndrome, a group of disorders
CC       characterized by failure of neuromuscular transmission, including
CC       pre-synaptic, synaptic, and post-synaptic disorders that are not
CC       of autoimmune origin. Clinical features are easy fatigability and
CC       muscle weakness. CMS14 is an autosomal recessive form
CC       characterized by onset of limb-girdle muscle weakness in early
CC       childhood. The disorder is slowly progressive, and some patients
CC       may become wheelchair-bound. {ECO:0000269|PubMed:23404334}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- SIMILARITY: Belongs to the glycosyltransferase group 1 family.
CC       Glycosyltransferase 4 subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB161356; BAD11905.1; -; mRNA.
DR   EMBL; AY358697; AAQ89060.1; -; mRNA.
DR   EMBL; AK027417; BAB55099.1; -; mRNA.
DR   EMBL; AK074704; BAC11150.1; -; mRNA.
DR   EMBL; AK074988; BAC11337.1; -; mRNA.
DR   EMBL; AK075172; BAC11449.1; -; mRNA.
DR   EMBL; AL137067; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC017876; AAH17876.1; -; mRNA.
DR   CCDS; CCDS6739.1; -. [Q9H553-1]
DR   RefSeq; NP_149078.1; NM_033087.3. [Q9H553-1]
DR   UniGene; Hs.40919; -.
DR   ProteinModelPortal; Q9H553; -.
DR   BioGrid; 124493; 18.
DR   STRING; 9606.ENSP00000417764; -.
DR   CAZy; GT4; Glycosyltransferase Family 4.
DR   iPTMnet; Q9H553; -.
DR   PhosphoSitePlus; Q9H553; -.
DR   BioMuta; ALG2; -.
DR   DMDM; 46395991; -.
DR   EPD; Q9H553; -.
DR   MaxQB; Q9H553; -.
DR   PaxDb; Q9H553; -.
DR   PeptideAtlas; Q9H553; -.
DR   PRIDE; Q9H553; -.
DR   DNASU; 85365; -.
DR   Ensembl; ENST00000319033; ENSP00000326609; ENSG00000119523. [Q9H553-2]
DR   Ensembl; ENST00000476832; ENSP00000417764; ENSG00000119523. [Q9H553-1]
DR   GeneID; 85365; -.
DR   KEGG; hsa:85365; -.
DR   UCSC; uc004azf.4; human. [Q9H553-1]
DR   CTD; 85365; -.
DR   DisGeNET; 85365; -.
DR   GeneCards; ALG2; -.
DR   GeneReviews; ALG2; -.
DR   H-InvDB; HIX0019474; -.
DR   HGNC; HGNC:23159; ALG2.
DR   HPA; HPA041512; -.
DR   HPA; HPA041601; -.
DR   MalaCards; ALG2; -.
DR   MIM; 607905; gene.
DR   MIM; 607906; phenotype.
DR   MIM; 616228; phenotype.
DR   neXtProt; NX_Q9H553; -.
DR   OpenTargets; ENSG00000119523; -.
DR   Orphanet; 79326; ALG2-CDG.
DR   Orphanet; 353327; Congenital myasthenic syndromes with glycosylation defect.
DR   PharmGKB; PA134956849; -.
DR   eggNOG; KOG0853; Eukaryota.
DR   eggNOG; COG0438; LUCA.
DR   GeneTree; ENSGT00550000075033; -.
DR   HOGENOM; HOG000177048; -.
DR   HOVERGEN; HBG009445; -.
DR   InParanoid; Q9H553; -.
DR   KO; K03843; -.
DR   OMA; QIWTAHY; -.
DR   OrthoDB; EOG091G0AE2; -.
DR   PhylomeDB; Q9H553; -.
DR   TreeFam; TF106000; -.
DR   BRENDA; 2.4.1.132; 2681.
DR   Reactome; R-HSA-446193; Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein.
DR   UniPathway; UPA00378; -.
DR   ChiTaRS; ALG2; human.
DR   GeneWiki; ALG2; -.
DR   GenomeRNAi; 85365; -.
DR   PRO; PR:Q9H553; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   Bgee; ENSG00000119523; -.
DR   CleanEx; HS_ALG2; -.
DR   ExpressionAtlas; Q9H553; baseline and differential.
DR   Genevisible; Q9H553; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IBA:GO_Central.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:UniProtKB.
DR   GO; GO:0000033; F:alpha-1,3-mannosyltransferase activity; IDA:UniProtKB.
DR   GO; GO:0048306; F:calcium-dependent protein binding; IMP:UniProtKB.
DR   GO; GO:0004378; F:GDP-Man:Man1GlcNAc2-PP-Dol alpha-1,3-mannosyltransferase activity; IEA:UniProtKB-EC.
DR   GO; GO:0102704; F:GDP-Man:Man2GlcNAc2-PP-dolichol alpha-1,6-mannosyltransferase activity; IEA:UniProtKB-EC.
DR   GO; GO:0046982; F:protein heterodimerization activity; IPI:UniProtKB.
DR   GO; GO:0047485; F:protein N-terminus binding; IPI:UniProtKB.
DR   GO; GO:0006488; P:dolichol-linked oligosaccharide biosynthetic process; IGI:UniProtKB.
DR   GO; GO:0033577; P:protein glycosylation in endoplasmic reticulum; IGI:UniProtKB.
DR   GO; GO:0051592; P:response to calcium ion; IDA:UniProtKB.
DR   InterPro; IPR001296; Glyco_trans_1.
DR   InterPro; IPR028098; Glyco_trans_4-like_N.
DR   Pfam; PF13439; Glyco_transf_4; 1.
DR   Pfam; PF00534; Glycos_transf_1; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome;
KW   Congenital disorder of glycosylation; Congenital myasthenic syndrome;
KW   Disease mutation; Glycosyltransferase; Membrane; Polymorphism;
KW   Reference proteome; Transferase; Transmembrane; Transmembrane helix.
FT   CHAIN         1    416       Alpha-1,3/1,6-mannosyltransferase ALG2.
FT                                /FTId=PRO_0000080260.
FT   TRANSMEM     85    105       Helical. {ECO:0000255}.
FT   VAR_SEQ       1     91       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:12975309,
FT                                ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_013188.
FT   VAR_SEQ      92    116       VRMVFLALYVLFLADEEFDVVVCDQ -> MPLLKLVHGSPL
FT                                VFGEKFKLFTL (in isoform 2).
FT                                {ECO:0000303|PubMed:12975309,
FT                                ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_013189.
FT   VARIANT      11     11       S -> P (in dbSNP:rs11545137).
FT                                /FTId=VAR_049351.
FT   VARIANT      68     68       V -> G (in CMS14; shows severely reduced
FT                                expression of the mutant protein;
FT                                dbSNP:rs730882051).
FT                                {ECO:0000269|PubMed:23404334}.
FT                                /FTId=VAR_073332.
FT   VARIANT     367    367       V -> A (in dbSNP:rs35626507).
FT                                /FTId=VAR_049352.
FT   CONFLICT    178    178       Q -> R (in Ref. 2; BAC11449).
FT                                {ECO:0000305}.
SQ   SEQUENCE   416 AA;  47092 MW;  778DB1FD069E7F29 CRC64;
     MAEEQGRERD SVPKPSVLFL HPDLGVGGAE RLVLDAALAL QARGCSVKIW TAHYDPGHCF
     AESRELPVRC AGDWLPRGLG WGGRGAAVCA YVRMVFLALY VLFLADEEFD VVVCDQVSAC
     IPVFRLARRR KKILFYCHFP DLLLTKRDSF LKRLYRAPID WIEEYTTGMA DCILVNSQFT
     AAVFKETFKS LSHIDPDVLY PSLNVTSFDS VVPEKLDDLV PKGKKFLLLS INRYERKKNL
     TLALEALVQL RGRLTSQDWE RVHLIVAGGY DERVLENVEH YQELKKMVQQ SDLGQYVTFL
     RSFSDKQKIS LLHSCTCVLY TPSNEHFGIV PLEAMYMQCP VIAVNSGGPL ESIDHSVTGF
     LCEPDPVHFS EAIEKFIREP SLKATMGLAG RARVKEKFSP EAFTEQLYRY VTKLLV
//
